InterCure Ltd. - INCR

INCR Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
INCR	1.0	-1.3	4.7	0.4	-29.2	38.8	-71.1	36.6	-99.3	-99.3
S&P 500	-1.9	-1.6	0.3	3.1	9.7	21.5	38.4	84.6	195.0	33801.6

Compare INCR with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	INCR
name	InterCure Ltd.
price	1.7072
changes percentage	1.0178
change	0.0172
day low	1.7
day high	1.735
year high	3.72
year low	1.17
market cap	78130691
price avg 50	1.49992
price avg 200	2.077855
exchange	NASDAQ
volume	7808
avg volume	41455
open	1.73
previous close	1.69
eps	-0.4
pe	-4.27
earnings announcement	2024-08-30T16:45:43.000+0000
shares outstanding	45765400
timestamp	2025-01-27 17:03:29

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 26.0%

Overall Quarterly Financial Health: 33.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001857030
revenue	355553000	388684000	-8.52
gross profit	105095000	155083000	-32.23
gross profit ratio	0.3	0.4	-25.92
research and development expenses	388000	632000	-38.61
operating expenses	146662000	102154000	43.57
interest income	4547000	844000	438.74
interest expense	24219000	14689000	64.88
ebitda	-23900000	64501000	-137.05
ebitdaratio	-0.07	0.17	-140.51
operating income	-41567000	52802000	-178.72
operating income ratio	-0.12	0.14	-186.06
net income	-61959000	44819000	-238.24
net income ratio	-0.17	0.12	-251.12
eps	-1.36	0.99	-237.37

Overall Score of Annual Income Statement

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 356 million in 2023 from 389 million in 2022 representing a change of -8.52%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 105 million in 2023 from 155 million in 2022 representing a change of -32.23%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2023 from 1 million in 2022 representing a change of -38.61%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 147 million in 2023 from 102 million in 2022 representing a change of 43.57%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -24 million in 2023 from 65 million in 2022 representing a change of -137.05%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to -42 million in 2023 from 53 million in 2022 representing a change of -178.72%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -62 million in 2023 from 45 million in 2022 representing a change of -238.24%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -1.36 in 2023 from -1.36 in 2022 representing a change of -237.37%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001857030
revenue	62866500	62866500	0.0
gross profit	20830000	20830000	0.0
gross profit ratio	0.33	0.33	0.0
research and development expenses	109500	109500	0.0
operating expenses	15573500	15573500	0.0
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	7202000	7202000	0.0
ebitdaratio	0.11	0.11	0.0
operating income	5256500	5256500	0.0
operating income ratio	0.08	0.08	0.0
net income	716500	716500	0.0
net income ratio	0.01	0.01	0.0
eps	0.01	0.01	0.0

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001857030
total assets	786614000	958007000	-17.89
total liabilities	329552000	436530000	-24.51
total equity	457062000	521477000	-12.35
cash and cash equivalents	101139000	232589000	-56.52
short term investments	187000	205000	-8.78
long term investments	1922000	42565000	-95.48
total current assets	418804000	507493000	-17.48
total non current assets	367810000	450514000	-18.36
total current liabilities	225868000	312719000	-27.77
total non current liabilities	103684000	123811000	-16.26
common stock	643158000	632025000	1.76
retained earnings	-203995000	-141649000	-44.01
total debt	195677000	255160000	-23.31

Overall Score of Annual Balance Sheet

0.4 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 787 million in 2023 from 958 million in 2022 representing a change of -17.89%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 457 million in 2023 from 521 million in 2022 representing a change of -12.35%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 101 million in 2023 from 233 million in 2022 representing a change of -56.52%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 0 million in 2022 representing a change of -8.78%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 419 million in 2023 from 507 million in 2022 representing a change of -17.48%. This indicates a worsen liquidity position.

  Retained Earnings: Retained Earnings decreased to -204 million in 2023 from -142 million in 2022 representing a change of -44.01%. This indicates an accumulated losses.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 330 million in 2023 from 437 million in 2022 representing a change of -24.51%. This indicates a decrease in overall liabilities.

  Total Current Liabilities: Total Current Liabilities decreased to 226 million in 2023 from 313 million in 2022 representing a change of -27.77%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 643 in 2023 from 632 in 2022 representing a change of 1.76%. This indicates an increase in ownership interest.

  Total Debt: Total Debt decreased to 196 million in 2023 from 255 million in 2022 representing a change of -23.31%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001857030
total assets	740887000	740887000	0.00
total liabilities	278772000	278772000	0.00
total equity	462115000	462115000	0.00
cash and cash equivalents	19899000	19899000	0.00
short term investments	399000	399000	0.00
long term investments	20369000	20369000	0.00
total current assets	370817000	370817000	0.00
total non current assets	370070000	370070000	0.00
total current liabilities	208873000	208873000	0.00
total non current liabilities	69899000	69899000	0.00
common stock	649013000	649013000	0.00
retained earnings	-204518000	-204518000	0.00
total debt	150813000	133072000	13.33

Overall Score of Quarterly Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Debt: Total Debt increased to 151 million in 2024Q2 from 133 million in 2024Q1 representing a change of 13.33%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001857030
net change in cash	-131450000	36372000	-461.40
operating cash flow	-53631000	51267000	-204.61
free cash flow	-56250000	31525000	-278.43
capital expenditure	-2619000	-19742000	86.73
depreciation and amortization	13166000	11699000	12.54
deferred income tax	2248000	93000	2317.20
stock based compensation	2592000	8907000	-70.90
accounts payables	-47627000	57033000	-183.51
inventory	40207000	-75988000	152.91
acquisitions net	-4200000	-8316000	49.49
investments in property plant and equipment	-2619000	-19742000	86.73
net cash used for investing activites	4773000	-142497000	103.35
debt repayment	-61982000	137730000	-145.00
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-82889000	120446000	-168.82
cash at end of period	101139000	232589000	-56.52
accounts receivables	-23492000	-18286000	-28.47
cash at beginning of period	232589000	196217000	18.54

Overall Score of Annual Cashflow Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -131 million in 2023 from 36 million in 2022 representing a change of -461.4%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to -54 million in 2023 from 51 million in 2022 representing a change of -204.61%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -56 million in 2023 from 32 million in 2022 representing a change of -278.43%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -3 million in 2023 from -20 million in 2022 representing a change of 86.73%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 2 million in 2023 from 0 million in 2022 representing a change of 2317.2%. This indicates that the company's tax liability for future periods has increased.

• 📈 Positive Indicators

  Stock-Based Compensation: Stock-Based Compensation decreased to 3 million in 2023 from 9 million in 2022 representing a change of -70.9%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 48 million in 2023 from 57 million in 2022 representing a change of -183.51%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -23 million in 2023 from -18 million in 2022 representing a change of -28.47%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001857030
operating cash flow	0	0	NaN
free cash flow	0	0	NaN
capital expenditure	0	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	343000	343000	0.0
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	0	0	NaN
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	0	0	NaN
net change in cash	0	0	NaN
cash at end of period	0	0	NaN
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q4 2022 Earnings call transcript
Q2 2022 Earnings call transcript
Q1 2022 Earnings call transcript
Q3 2021 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	7.8	8.57	-8.94
net income per share	-1.36	0.99	-237.62
operating cash flow per share	-1.18	1.13	-204.14
free cash flow per share	-1.23	0.7	-277.62
cash per share	2.22	5.13	-56.67
book value per share	10.03	11.5	-12.75
tangible book value per share	5.18	5.23	-1.00
shareholders equity per share	9.99	11.05	-9.62
interest debt per share	4.83	5.95	-18.88
market cap	223143676.66	565546934.47	-60.54
enterprise value	317681676.66	588117934.47	-45.98
pe ratio	-3.6	12.62	-128.54
price to sales ratio	0.63	1.46	-56.87
pocfratio	-4.16	11.03	-137.72
pfcf ratio	-3.97	17.94	-122.11
pb ratio	0.49	1.13	-56.54
ptb ratio	0.49	1.13	-56.54
ev to sales	0.89	1.51	-40.95
enterprise value over ebitda	-13.29	9.12	-245.78
ev to operating cash flow	-5.92	11.47	-151.64
ev to free cash flow	-5.65	18.66	-130.27
earnings yield	-0.28	0.08	-450.37
free cash flow yield	-0.25	0.06	-552.22
debt to equity	0.43	0.51	-15.53
debt to assets	0.25	0.27	-6.60
net debt to ebitda	-3.96	0.35	-1230.38
current ratio	1.85	1.62	14.26
interest coverage	-1.72	3.59	-147.75
income quality	0.84	1.17	-27.96
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.18	0.24	-23.36
research and ddevelopement to revenue	0.0	0.0	-32.89
intangibles to total assets	0.28	0.3	-5.25
capex to operating cash flow	-0.05	0.39	-112.68
capex to revenue	0.01	0.05	-85.50
capex to depreciation	0.2	1.69	-88.21
stock based compensation to revenue	0.01	0.02	-68.19
graham number	17.48	15.68	11.52
roic	-0.07	0.07	-197.31
return on tangible assets	-0.11	0.07	-264.71
graham net net	-2.84	-2.42	-17.05
working capital	192936000	194774000	-0.94
tangible asset value	235982000	237296000	-0.55
net current asset value	89252000	70963000	25.77
invested capital	511489000	582088000	-12.13
average receivables	50941500	39145500	30.13
average payables	102253500	95270500	7.33
average inventory	116394500	97188500	19.76
days sales outstanding	62.75	38.28	63.94
days payables outstanding	114.31	196.98	-41.97
days of inventory on hand	154.9	197.65	-21.63
receivables turnover	5.82	9.54	-39.00
payables turnover	3.19	1.85	72.32
inventory turnover	2.36	1.85	27.60
roe	-0.14	0.09	-252.27
capex per share	0.06	0.44	-86.79

• Negative

  ROE: Return on Equity (ROE) decreased to -0.14 on 2023-12-31 from 0.09 on 2022-12-31, representing a change of -252.27%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -3.60 on 2023-12-31 from 12.62 on 2022-12-31, representing a change of -128.54%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.85 on 2023-12-31 from 1.62 on 2022-12-31, representing a change of 14.26%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.43 on 2023-12-31 from 0.51 on 2022-12-31, representing a change of -15.53%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
INCR
calendar year	2024	2024	NaN
revenue per share	1.32	1.32	0.00
net income per share	0.02	0.02	0.00
operating cash flow per share	0	0	NaN
free cash flow per share	0	0	NaN
cash per share	0.42	0.42	0.00
book value per share	9.67	9.67	0.00
tangible book value per share	4.99	4.99	0.00
shareholders equity per share	9.64	9.64	0.00
interest debt per share	3.16	2.79	13.33
market cap	382324394.66	457939026.94	-16.51
enterprise value	513238394.66	571112026.94	-10.13
pe ratio	133.4	159.78	-16.51
price to sales ratio	6.08	7.28	-16.51
pocfratio	0	0	NaN
pfcf ratio	0	0	NaN
pb ratio	0.83	0.99	-16.51
ptb ratio	0.83	0.99	-16.51
ev to sales	8.16	9.08	-10.13
enterprise value over ebitda	71.26	79.3	-10.13
ev to operating cash flow	0	0	NaN
ev to free cash flow	0	0	NaN
earnings yield	0.0	0.0	19.78
free cash flow yield	0	0	NaN
debt to equity	0.33	0.29	13.33
debt to assets	0.2	0.18	13.33
net debt to ebitda	18.18	15.71	15.68
current ratio	1.78	1.78	0.00
interest coverage	0	0	NaN
income quality	0	0	NaN
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.15	0.15	0.00
research and ddevelopement to revenue	0.0	0.0	0.00
intangibles to total assets	0.3	0.3	0.00
capex to operating cash flow	0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0.01	0.01	0.00
graham number	1.8	1.8	0.00
roic	-0.0	-0.0	0.00
return on tangible assets	0.0	0.0	0.00
graham net net	-3.12	-3.12	0.00
working capital	161944000	161944000	0.00
tangible asset value	238506000	238506000	0.00
net current asset value	92045000	92045000	0.00
invested capital	484164000	484164000	0.00
average receivables	61672000	61398000	0.45
average payables	83071000	80755500	2.87
average inventory	126466000	115967500	9.05
days sales outstanding	88.29	88.29	0.00
days payables outstanding	177.85	177.85	0.00
days of inventory on hand	270.76	270.76	0.00
receivables turnover	1.02	1.02	0.00
payables turnover	0.51	0.51	0.00
inventory turnover	0.33	0.33	0.00
roe	0.0	0.0	0.00
capex per share	0	0	NaN

• Negative

  ROE: Return on Equity (ROE) decreased to 0.00 on 2024-06-30 Q2 from 0.00 on 2024-03-31 Q1, representing a change of 0.00%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 133.40 on 2024-06-30 Q2 from 159.78 on 2024-03-31 Q1, representing a change of -16.51%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.78 on 2024-06-30 Q2 from 1.78 on 2024-03-31 Q1, representing a change of 0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.33 on 2024-06-30 Q2 from 0.29 on 2024-03-31 Q1, representing a change of 13.33%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None